Medigus Ltd ADR

NASDAQ MDGS

Download Data

Medigus Ltd ADR Revenue for the quarter ending June 30, 2023: USD 53.38 M

Medigus Ltd ADR Revenue is USD 53.38 M for the quarter ending June 30, 2023. The revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Medigus Ltd ADR Revenue for the quarter ending June 30, 2019 was USD 144.00 K, a 166.67% change year over year.
NASDAQ: MDGS

Medigus Ltd ADR

CEO Mr. Liron Carmel
IPO Date Aug. 5, 2015
Location Israel
Headquarters Building B, Tel Aviv, Israel, 6971068
Employees 77
Sector Healthcare
Industry Medical devices
Description

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Similar companies

SRDX

SurModics Inc

NA

NA

NSYS

Nortech Systems Incorporated

NA

NA

StockViz Staff

September 16, 2024

Any question? Send us an email